We also evaluated for the consequence of high expression of B4GALT3 on breast cancer patient survival and alike ovarian cancer, no significant adverse effect was observed for breast cancer patients expressing high B4GALT3 (Supplementary Fig. S1; B). Here, B4GALT3 is linked to breast carcinoma.